BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22393910)

  • 21. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
    Wang T; Yu X; He C
    Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
    van Staa TP; Leufkens HG; Cooper C
    Osteoporos Int; 2002 Oct; 13(10):777-87. PubMed ID: 12378366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
    Lems WF; Saag K
    Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucocorticoid-induced osteoporosis].
    Yasuda S; Kogawa M; Wada S
    Nihon Rinsho; 2003 Feb; 61(2):280-6. PubMed ID: 12638222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An update on glucocorticoid-induced osteoporosis].
    Krasselt M; Baerwald C
    Dtsch Med Wochenschr; 2016 Mar; 141(5):352-7. PubMed ID: 26939107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
    Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.
    Lane NE
    Curr Osteoporos Rep; 2019 Feb; 17(1):1-7. PubMed ID: 30685820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.
    Brabnikova Maresova K; Pavelka K; Stepan JJ
    Calcif Tissue Int; 2013 Apr; 92(4):354-61. PubMed ID: 23247536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids and the osteoclast.
    Teitelbaum SL
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S37-9. PubMed ID: 26458014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of glucocorticoid-induced osteoporosis.
    Canalis E
    Curr Opin Rheumatol; 2003 Jul; 15(4):454-7. PubMed ID: 12819474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glucocorticoid and Bone. Significance of serum soluble RANKL measurement in patients under glucocorticoid therapy].
    Kaneko K; Kawai S
    Clin Calcium; 2014 Sep; 24(9):1361-70. PubMed ID: 25177009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid-induced osteoporosis.
    Tamura Y; Okinaga H; Takami H
    Biomed Pharmacother; 2004 Nov; 58(9):500-4. PubMed ID: 15511606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of cortisone-induced osteoporosis].
    Trombetti A; Ferrari S; Stoermann-Chopard C; Rizzoli R
    Praxis (Bern 1994); 2004 Mar; 93(11):407-14. PubMed ID: 15061108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid-induced osteoporosis in dermatologic practice: a review.
    Khan YK; Kalaaji AN; Clarke BL
    J Drugs Dermatol; 2008 Nov; 7(11):1053-9. PubMed ID: 19110736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.